baber/WOPTO huggingface dataset:
Patent NZ-243226-A (NZ)
Title: Mechanical fastening system and manufacture thereof - prongs formed on substrate when molten material is forced through apertures of a depositing member
Inventor: THOMAS DENNIS ALBERT
IPC: B29C48/18
Filed: 1992-06-19
Abstract: The invention is a refastenable mechanical fastening system, made of free formed prongs joined to a substrate. The prongs taper and are nonperpendicularly oriented relative to the plane of the substrate. The prongs may also have an azimuthal angle relative to the machine direction of the substrate. Each prong has an engaging means projecting laterally from the periphery of the prong. The free formed prongs are manufactured by the process of extruding liquid material through the meshes of a deposting member onto a moving substrate to form the base of the prong, stretching the liquid material in a direction parallel to the plane of the substrate, severing the stretched material to form the distal end and engaging means of the prong. The advantageous usage of the fastening system in an article of manufacture, such as a disposable absorbent article specifically a diaper, is also disclosed.
Patent NZ-280151-A (NZ)
Title: Heat-shrinkable, multilayer packaging film which maintains transparency after shrinking
Inventor: BABROWICZ ROBERT
IPC: B65D65/40
Filed: 1995-10-02
Abstract: A multilayer film comprising a bulk core layer which comprises a homogeneous ethylene/alpha-olefin copolymer, the multilayer film having a total free shrink of at least 80 percent at 85 DEG C (185 DEG F) exhibits a surprisingly high level of impact strength per unit of film thickness.
Patent NZ-284766-A (NZ)
Title: Perfluoro amino ketones; medicaments as elastase inhibitors
Inventor: METZ WILLIAM ARTHUR
IPC: A61K38/00
Filed: 1995-05-01
Abstract: PCT No. PCT/US95/05363 Sec. 371 Date Nov. 22, 1996 Sec. 102(e) Date Nov. 22, 1996 PCT Filed May 1, 1995 PCT Pub. No. WO95/33762 PCT Pub. Date Dec. 14, 1995This invention relates to compounds which are inhibitors of elastase, particularly human neutrophil elastase, and to novel processes for making the same. As inhibitors of human neutrophil elastase, the compounds are useful in the treatment of a patient afflicted with a neutrophil associated inflammatory disease.
Patent NZ-289562-A (NZ)
Title: Solution phase and solid phase methods for the synthesis of peptidyl argininal derivatives and salts thereof
Inventor: WEBB THOMAS R
IPC: C07D207/16
Filed: 1995-06-19
Abstract: This invention provides solution-phase and solid-phase methods for the synthesis of peptidyl argininals and to novel reagents useful therein, which have formula (I), wherein R1 is selected from the group consisting of hydrogen, benzyloxycarbonyl, isonicotinyloxycarbonyl, 2-chlorobenzyloxycarbonyl, 4-methoxybenzyloxycarbonyl, t-butoxycarbonyl, t-amyloxycarbonyl, isobornyloxycarbonyl, adamantyloxycarbonyl, 2-(4-biphenyl)-2-propyloxycarbonyl, 9-fluorenylmethoxycarbonyl and methylsulfonylethoxycarbonyl; R2 is selected from the group consisting of alkyl of 1 to about 12 carbon atoms and aralkyl of about 7 to about 15 carbon atoms, either of which is optionally substituted with hydroxy or -CO-Y, wherein Y is hydroxy, alkoxy of 1 to about 12 carbon atoms, aralkoxy of about 7 to about 15 carbon atoms, O-polymeric support or NH-polymeric support; R3 is selected from the group consisting of hydrogen, Fmoc, nitro, benzyloxycarbonyl, t-butoxycarbonyl and adamantyloxycarbonyl; and R4 is selected from the group consisting of hydrogen, alkyl of 1 to about 12 carbon atoms, aryl of about 6 to about 14 carbon atoms and aralkyl of about 7 to about 15 carbon atoms; and salts thereof.
Patent NZ-298122-A (NZ)
Title: Application of a bituminous substance to wood to prevent decay
Inventor: GEORGE RICHARD WARRINGTON
IPC: B29C61/06
Filed: 1996-01-12
Abstract: PCT No. PCT/GB96/00049 Sec. 371 Date Aug. 5, 1997 Sec. 102(e) Date Aug. 5, 1997 PCT Filed Jan. 12, 1996 PCT Pub. No. WO96/25277 PCT Pub. Date Aug. 22, 1996A method in which a flexible outer barrier layer is applied to at least that part of the object most vulnerable to decay, a bituminous substance is provided between the outer barrier layer and the object, and the barrier layer is heated so as to melt the bituminous substance sufficiently for it to bond intimately to the wooden object. The barrier layer may be a heat shrinkable plastic film and may be a sleeve which is heat shrunk onto the object. The invention is particularly useful for protecting vulnerable parts of elongate wooden objects, such as fence posts or poles, from decay.
Patent NZ-305940-A (NZ)
Title: N-(aroyl)glycine hydroxamic acid derivatives and related compounds that inhibit the production of tnf and are useful in treating asthma
Inventor: KLEINMAN EDWARD F
IPC: A61K31/4015
Filed: 1996-05-14
Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, AA and Y are as defined herein, inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor, and therefore are useful in the treatment of certain conditions and diseases including asthma, arthritis, and sepsis.
Patent NZ-319169-A (NZ)
Title: Imidazole derivatives as <alpha>-2 agonists
Inventor: KARJALAINEN ARTO
IPC: C07D233/56
Filed: 1996-10-02
Abstract: Imidazole derivatives of formula (I)wherein n is 0 or 1, R1 is hydrogen or C1-C4-alkyl, R2 is hydrogen or R2 and R3 together form a double bond, R3 is hydrogen or C1-C4-alkyl or R2 and R3 together form a double bond, R4 is hydrogen, C1-C4-alkyl, hydroxy or C1-C4-alkoxy, R5 is hydrogen or C1-C4-alkyl or R4 and R5 together with the carbon atom to which they are attached form a carbonyl group, R6, R7 and R8 are each the same or different and are independently hydrogen, C1-C4-alkyl or C2-C4-alkenyl, C3-C7-cycloalkyl, hydroxy, C1-C4-alkoxy, C1-C4-hydroxyalkyl, thiol, C1-4-alkylthio, C1-4-alkylthiol, halogen, trifluoromethyl, nitro or optionally substituted amino, X is -CHR9-(CHR10)m-, m is 0 or 1, and R9 and R10 are each the same or different and are independently hydrogen or C1-C4-alkyl; or a pharmaceutically acceptable ester or salt thereof, their preparation, use and pharmaceutical compositions comprising them are described. The compounds have affinity for alpha2 receptors and are useful e.g. in the treatment of hypertension, glaucoma, chronic or acute pain, migraine, diarrhea, common cold, ischemia, addiction to chemical substances, anxiety, especially preoperative anxiety and different neurological, musculoskeletal, psychiatric and cognition disorders or as adjuncts to anesthesia.
Patent NZ-332274-A (NZ)
Title: Baking oil coated french fries
Inventor: TAYLOR KYLE MCLENNAN
IPC: A23L5/10
Filed: 1997-04-16
Abstract: A method, for oven finishing (baking) oil-enrobed prebake fries in as little as 0.75 minute at a temperature of from 325 °F (162 °C) to 800 °F (426 °C), provides oven-finished French fries that have virtually the same taste and characteristics as deep fat fried finished French fries.  The method comprises baking an oil enrobed prebake parfry having from 34-58% moisture, from 6-30% fat and a surface coating of oil.  The oven-finished French fries have a bulk moisture of from 32 % to 53 %, a total fat content of from 8% to 25 % and a French Fry Texture Value of at least 200.  Preferably the fries have a surface water activity (Aw) of less than 0.55 and an internal moisture content of from 55 % to 80 %.
Patent NZ-332673-A (NZ)
Title: Vial for use as syringe accessory
Inventor: VAN DER MEYDEN HENDRIKUS JOHAN
IPC: A61M5/28
Filed: 1997-05-06
Abstract: A vial comprises a tubular syringe barrel (1) closed at one end (2) and open at the other, a stopper in the open barrel end formed by a piston head (4) of a syringe, and valve means (10) in the barrel between the stopper and the closed barrel end. The valve means (1) is normally closed and actuatable to an open condition by movement of the stopper into the barrel, and is slidable with the piston head (4) to the closed barrel end (2).
Patent NZ-334795-A (NZ)
Title: Fuel combustion enhancing catalytic composition and methods of formulating and utilizing same
Inventor: LACK LLOYD
IPC: C10L1/06
Filed: 1996-12-26
Abstract: A composition for enhancing combustion of LPG fuel, comprising at least one metal oxide catalyst which is a mixture of chromium oxide and cobalt oxide dispersed in an organic carrier specifically Stoddard solvent which is compatible with the LPG fuel. Further described is a method of combusting LPG fuel by using the composition and combusting at a temperature below 1500oC.
Patent NZ-334817-A (NZ)
Title: Process for the manufacture of iohexol
Inventor: MALTHE-SORENSSEN DICK
IPC: C07C237/46
Filed: 1997-08-29
Abstract: A process for the production of iohexol which comprising the steps of, 1) reacting 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide with a 2,3-dihydroxypropylating agent, in the presence of a reaction solvent which comprises 2-methoxy-ethanol and, optionally, isopropanol to provide a solution of crude iohexol, 2) purifying the crude iohexol in a solvent comprising isopropanol and 2-methoxy-ethanol in a volume ratio of from 93:7 to 85:15, causing iohexol to separate in solid form and 3) washing the solid iohexol with a further solvent comprising isopropanol to yield iohexol.
Patent NZ-335211-A (NZ)
Title: Micro-organism Ochrobactrum anthropi and method for degradation of moniliformin in grain
Inventor: DUVICK JON
IPC: A01N63/20
Filed: 1997-11-12
Abstract: The present invention relates to a microorganism comprising a bacterium of an Ochrobactrum species like Ochrobactrum anthropi , having the ability to degrade moniliformin. Also claimed is a method of degrading moniliformin on a harvested grain by applying a microorganism above which is capable of degrading moniliformin to the harvested grain.
Patent NZ-336638-A (NZ)
Title: Transdermal therapeutic system
Inventor: DITTGEN MICHAEL
IPC: A61K9/70
Filed: 1998-01-13
Abstract: A transdermal therapeutic system for the delivery of an active ingredient across the skin and/or a mucosal surface. The system consists of at least one active ingredient as a solid dispersion in a common matrix with at lease one structuring agent and at least one destructuring agent. In particular the solid dispersion is a molecular dispersion in an inert carrier. Possible active ingredients include hormones, immunomodulators, immunosuppressants, antibiotics, cytostatics, diuretics, gastrointestinal agents, cardiovascular agents, and neuropharmaceuticals. Possible destructuring agents include carboxamides, and possible structuring agents include polyols, sugar alcohols, and sugars, or mixtures thereof. Possible matrixes include sheet-like adhesive pieces of material, plasters, patches, gels, ointments, creams, emulsions, embrocations, paints and impregnated fabrics. Also disclosed is a composition for transdermal administration comprised as above, where the structuring agent is of formula 1, where R1 and R2 are identical or different (C1-C6) Alkyl radicals, and R3 is a hydroxy-(C1-C6)alkyl radical.
Patent NZ-500920-A (NZ)
Title: Production of non-group C replication deficient adenovirus having a genome deficient in E1 region gene function
Inventor: FALCK-PEDERSEN ERIK
IPC: A61K48/00
Filed: 1998-05-20
Abstract: A replication deficient adenovirus comprising a passenger gene and having a deficiency in an essential gene function of the E1 region of the adenoviral genome, may be produced in a cell that provides in trans gene functions of the E1 and E4 regions of one or more adenoviruses not belonging to the same serogroup as the replication deficient adenovirus.
Patent NZ-501672-A (NZ)
Title: Proliposome powders for inhalation stabilised by racemic alpha-tocopherol
Inventor: NILSSON PER-GUNNAR
IPC: A61K9/72
Filed: 1998-06-08
Abstract: The proliposome powder comprises discrete particles each comprising in a single phase; (1) a biologically active component selected from antiinflammatory and bronchorelaxing drugs, antihistamines, cyclooxygenase inhibitors, leukotriene synthesis inhibitors, leukotriene antagonists, phospholipase-A2 inhibitors, platelet aggregating factor antagonists, antiarrhythmic drugs, tranquilisers, cardiac glycosides, hormones, anti-hypertensive drugs, antidiabetic, antiparisitic and anticancer drugs, sedatives, analgesic drugs, antibiotics, antirheumatic drugs, immunotherapies, antifungal drugs, antihypotension drugs, vaccines, antiviral drugs, proteins, peptides and vitamins; (2) a stabilising proportion of tocopherol; and (3) a lipid or mixture of lipids having a phase transition temperature of below 37°C.
Patent NZ-501756-A (NZ)
Title: Using burst cutting areas to identify information on multilayer and dual sided DVD records
Inventor: XIE JIANLEI
IPC: G11B7/24038
Filed: 1998-06-16
Abstract: A system and method of identifying programs of any format contained on a Digital Video/Versatile Disks (DVDs), either a single or a double-sided disk with either a single or multi-layer tracks, are presented. A Burst Cutting Area (BCA) is defined, in which individualizable information can be stored via laser encoding. For example, the information may include an individualized serial number specific to that disk. This would allow for a pay-per-view system to be implemented. Also, as opposed to the current DVD Specifications of only 1 BCA-per-disk, multiple BCA allocations in one disk can be allowed. This would then allow for multiple programs/data on one disk, whereby the distribution of the multiple programs/data can be controlled via the BCA. Also disclosed is an apparatus for laser encoding the above-described recording medium, and a method for processing a disk having more than one laser encoded areas.
Patent NZ-504168-A (NZ)
Title: Digital multiplexer/demultiplexer with loopback interface
Inventor: BULLINGTON THOMAS E
IPC: H04J3/16
Filed: 1998-11-03
Abstract: A multiplexer device for multiplexing and demultiplexing signals between a low-speed network including 28 DSX-1 signals and a relatively higher speed network including a DS-3 signal includes 7 quad DSX-1 cards and 1 spare card. The spare card is connected to the other 7 DSX-1 cards in a fashion that allows the spare card to automatically be switched in for one of the DSX-1 cards or to allow interface electronics on the spare card to replace selected ones of the interface electronics on various different DSX-1 cards simultaneously. A pair of controller cards, a primary card and a secondary card, perform the M1-3 multiplexing and demultiplexing and the DS-3 framing and transceiving. The controller cards can be selected or deselected by distributed logic in a sufficiently short time period so that alarms are not set off and so that the transition is hitless. This is accomplished by electronically enabling and disabling the transceiver. The multiplexer device is connectable to 2 different T-3 links to provide network redundancy. An array of relays provides for the connection of either controller card to either of the T-3 links. The controller cards are externally connectable to a computer network such as an Ethernet for external control thereof through SNMP or Telnet sessions. The multiplexer device is housed within a significantly reduced volume which occupies only a single rack unit on a standard 19'' or 23'' wide vertical rack used for telecommunications equipment. The significantly reduced volume is partially due to a dual backplane architecture in which an external backplane serves as the external connector plane while a separate internal backplane serves as the connection to the various DSX-1 cards and controller cards.  The DSX-1 signals can include loopback codes requesting the reflection back of signals from a transmit portion from a transmit portion of the DSX-1 circuit into a receive portion of the DSX-1 circuit, and the multiplexer includes interface circuits that each include a detector to detect the loopback codes in the data passed through the DSX-1 circuits.  A loopback circuit in each of the interface circuits can be selectively switched in to reflect the signals from the transmit portion of the DSX-1 circuit to the receive portion of the DSX-1 circuit in response to the detection of the loopback code.
Patent NZ-506531-A (NZ)
Title: A lock for a sliding door or window with rotating hook bolts extended by actuator which contacts strike
Inventor: MIJUKOVIC ZORAN
IPC: E05B65/08
Filed: 2000-08-24
Abstract: A lock for a door or window has a pair of rotating hook bolts 11, 12 and an actuator 20, which extends from the lock body 10 and is the first part to contact a striker 14 when the door or window is closed. The actuator holds the hook bolts in the retracted position so that the bolts are not damaged when the door or the hook bolts which can then be rotated to the extended position. The arrangement is designed for hook bolts, which do not "ride" over a keeper. The lock is stated to increase security, as the hook bolts are more difficult to force open, and to use a new combination in the lock, which controls the hook, bolts.
Patent NZ-507981-A (NZ)
Title: Combination therapy for treatment of bipolar disorders
Inventor: TOLLEFSON GARY DENNIS
IPC: A61K31/445
Filed: 1999-05-21
Abstract: A use of olanzapine in combination with fluoxetine in the preparation of a medicament for the treatment of treatment resistant major depression in a patient in need thereof, such that the antidepressant effect of the medicament is earlier than with a monotherapy using a serotonin reuptake inhibitor alone.
Patent NZ-508717-A (NZ)
Title: Method of locking 1alpha-OH of vitamin D compounds in axial orientation
Inventor: DELUCA HECTOR F
IPC: C07C403/00
Filed: 1999-03-10
Abstract: A method of altering the conformational equilibrium of the A-ring of a 1a-hydroxylated vitamin D compound to lock the chair conformation of the A-ring in a geometry having an axially oriented 1a-hydroxyl, in order to increase its biological activity is disclosed, wherein the step of locking comprises: (1) adding a bond system to the A-ring, which is an anchoring bond system, a flattening bond system or a bridged bond system, or (2) modifying the A-ring by adding one or more substituents which interact with other substituents on the A-ring to provide a driving force to the A-ring to adopt a chair conformation which presents the 1a-hydroxyl in the axial orientation. These compounds may be suitable for treating diseases such as metabolic bone disease, diseases characterised by abnormal cell proliferation cell differentiation and disorders that are characterised by an imbalance in the immune system.
Patent NZ-510890-A (NZ)
Title: Process for preparing 1,5-diaryl-3-substituted pyrazoles
Inventor: ABDEL-MAGID AHMED F
IPC: C07C51/083
Filed: 2000-08-01
Abstract: Described  is a process for preparing  a  compound  of formula I, comprising: (A)   reacting  a  compound  of  formula  II  with  succinic anhydride  and  an  alkoxide base  to  form  a  compound  of formula III, (B) reacting the compound of formula III with a compound  of formula IV to form a compound of formula V, (C) reacting a compound of formula V with an alcohol to form the ester of formula VI, and (D)  reacting  the isolated ester with N-methylhydroxylamine hydrochloride to form the compound of formula I.
Patent NZ-511513-A (NZ)
Title: Embossed multi ply paper and process for producing the same
Inventor: MCNEIL KEVIN BENSON
IPC: B31F1/07
Filed: 1999-07-23
Abstract: An embossed multiple ply paper product and process for producing such product displaying aesthetically pleasing decorative attributes and exhibiting functional characteristics of softness, absorbency, and drape. The decorative attributes comprise embossed patterns of indicia displaying a high quality cloth-like appearance for a softer, more quilted look. The plies are joined in a face- to-face arrangement by selective bonds which are limited to the indicia, in order to produce more permanent decorative figures that inhibit dissipation caused by compressive forces, humidity, absorption, etc.
Patent NZ-515009-A (NZ)
Title: Clostridium strains which produce ethanol from substrate-containing gases
Inventor: GADDY JAMES L
IPC: C12P7/06
Filed: 1999-05-07
Abstract: Two anaerobic strains of Clostridium ljungdahlii are isolated from the contaminants with which they are associated in nature, and are useful in process for converting certain waste gases from industrial processes into useful products, e.g., ethanol.
Patent NZ-517694-A (NZ)
Title: Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
Inventor: GREEN JEREMY
IPC: A61P19/02
Filed: 2000-08-11
Abstract: Disclosed herein are compounds of formula (I), wherein R1 is H, CONH2, T(n)-R, or T(n)-Ar2; G is R or Ar1; R is an aliphatic or substituted aliphatic group; n may be zero or one; and Ar1, Ar2, XYZ, and Q are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of JNK, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. Also disclosed are methods for producing these inhibitors, and pharmaceutical compositions comprising these inhibitors and methods of utilizing those compositions in the treatment and prevention of various disorders.
Patent NZ-526735-A (NZ)
Title: Methods of organizing data and processing queries in a database system, and database system and software product for implementing such methods
Inventor: KOSKAS ELIE OUZI
IPC: G06F17/30
Filed: 2001-11-29
Abstract: A reference table has columns associated with data attributes and rows containing related words assigned to those attributes in a collection of data, those words coming from different data tables having independent numbers of records. The stored data include word thesauruses associated with the attributes, and reference table row identifier lists respectively associated with thesaurus entries. Each word thesaurus associated with an attribute has a respective entry for each word assigned to this data attribute in the collection of data. The reference table, which may be a virtual table, defines a unified algebraic framework for the entries of all the thesauruses. Query criteria can be examined with reference to the relevant thesauruses to obtain a row-ID list or bitmap vector which represents all the reference table rows matching the query criteria, if any. The results can then be delivered through the original data tables, or preferably, by means of the thesauruses.
Patent NZ-533249-A (NZ)
Title: Use of deoxypeganine for treating clinical depression
Inventor: MOORMANN JOACHIM
IPC: A61P25/28
Filed: 2002-12-14
Abstract: Disclosed is the use of deoxypeganine (desoxypeganine), as a free base or as an acid addition salt for the production of a drug for treating clinical depression.
Patent NZ-534979-A (NZ)
Title: Sawdust-free wood cutting method and apparatus
Inventor: LAVOIE JEROME
IPC: B31B50/25
Filed: 2003-02-14
Abstract: A sawdust-free wood cutting apparatus (10) comprises a guide (62, 72) for guiding a piece of wood (W) along a feed path having a cutting zone. At least one circular blade (18b) is mounted in the cutting zone and driven in rotation about an axis transversal to the feed path. The circular blade (18b) has a toothless circumferential cutting edge. A feeder (14, 16) advances the piece of wood (W) to be cut through the cutting zone at a linear speed substantially equal to a tangential speed at the toothless circumferential cutting edge of the circular blade (18b).